The University of Chicago Header Logo

Connection

Hans Schreiber to CTLA-4 Antigen

Back to Details
This is a "connection" page, showing publications Hans Schreiber has written about CTLA-4 Antigen.
Hans Schreiber
Connection Strength
0.445
CTLA-4 Antigen
  1. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors--letter. Cancer Res. 2014 Jan 15; 74(2):632; discussion 635.
    View in: PubMed
    Score: 0.445
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.